Protective immunity in BALB/c mice against the Simian Virus 40-induced mKSA tumor resulting from injection of recombinant large T antigen: Requirement of CD8+ T lymphocytes

Journal of Immunology

Volumn 156, Issue 10, 1996, Pages 3919-3924

  Zerrahn, Jens ^a   Utermöhlen, Olaf ^a   Warnecke, Gabriele ^a   Deppert, Wolfgang ^a   Lehmann Grube, Fritz ^a,b  

^a UNIVERSITY OF HAMBURG   (Germany)

^b LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; MONOCLONAL ANTIBODY; VIRUS ANTIGEN; VIRUS LARGE T ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; CYTOTOXIC T LYMPHOCYTE; FEMALE; GRAFT REJECTION; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PERITONEAL CAVITY; PRIORITY JOURNAL; SIMIAN VIRUS 40; T LYMPHOCYTE ACTIVATION; TUMOR IMMUNITY; VIRUS IMMUNITY;

ANIMALS; ANTIGENS, NEOPLASM; ANTIGENS, POLYOMAVIRUS TRANSFORMING; BASE SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; GRAFT REJECTION; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PAPILLOMAVIRUS INFECTIONS; SIMIAN VIRUS 40; T-LYMPHOCYTES, CYTOTOXIC; TUMOR VIRUS INFECTIONS; VACCINES, SYNTHETIC;

EID: 0029870462     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Schreiber, H. 1993 Tumor immunology In Fundamental Immunology, 3rd Ed W. E. Paul, ed Raven Press, New York, p 1143.
2. Melief, C. J. M. 1992. Tumor eradication by adoptive transfer of cytotoxic T lymphocytes. Adv. Cancer Res. 58:143.
3. Tevethia, S. S. 1990. Recognition of simian virus 40 T antigen by cytotoxic T lymphocytes. Mol. Biol. Med. 7:83.
4. Schirmbeck, R., J. Zerrahn, A. Kuhröber, W. Deppert, and J. Reimann. 1993. Immunization of mice with the N-terminal (1-272) fragment of simian virus 40 large T antigen (without adjuvants) specifically primes cytotoxic T lymphocytes Eur. J. Immunol. 23:1528
5. Kit, S., T. Kurimura, and D. R. Dubbs. 1969 Transplantable mouse tumor line induced by injection of SV40-transformed mouse kidney cells. Int. J Cancer 4:384.
6. Old, L. J., E. A. Boyse, D. A. Clarke, and E. A Carswell. 1962. Antigenic properties of chemically induced tumors. Ann N.Y. Acad. Sci. 101:80
7. Zerrahn, J., W. Deppert, D. Weidemann, T Patschinsky, F. Richards, and J. Milner. 1992. Correlation between the conformational phenotype of p53 and its subcellular location. Oncogene 7:1371.
8. Wiesmüller, L , J. Cammenga, and W. W. Deppert. 1996. In vivo assay of p53 function in homologous recombination between simian virus 40 chromosomes. J. Virol. 70:737.
9. Studier, F. W., and B. A. Moffat. 1986. Use of bacteriophage Υ7 RNA polymerase to direct selective high-level expression of cloned genes J. Mol. Biol. 189:113.
10. Rosenberg, A. H., B. N. Lade, D. Chui, S.-W. Lin, J. J. Dunn, and F. W Studier 1987. Vectors for selective expression of cloned DNAs by Υ7 RNA polymerase Gene 56:125.
11. Berthold, H., M. Scanarini, C. C. Abney, B. Frorath, and W. Northemann. 1992. Purification of recombinant antigenic epitopes of the human 68-kDa (U1) ribonucleoprotein antigen using the expression system pH6EX3 followed by metal chelating affinity chromatography. Prot. Expr. Purif. 3:50
12. Romanowski, V., Y. Matsuura, and D. H. L. Bishop 1985 Complete sequence of the S RNA of lymphocytic choriomeningitis virus (WE strain) compared to that of Pichinde arenavirus. Virus Res. 3:101.
13. Gurney, E. G., S. Tamowski, and W. Deppert. 1986. Antigenic binding sites of monoclonal antibodies specific for simian virus 40 large T antigen J. Virol. 57:1168.
14. MacArthur, H., and G. Walter. 1984. Monoclonal antibodies specific for the carboxy terminus of simian virus 40 large T antigen J. Virol. 52:483.
15. Qin, S., S. Cobbold, H. Tighe, R. Benjamin, and H. Waldmann. 1987. CD4 monoclonal antibody pairs for immunosuppression and tolerance induction. Eur J. Immunol 17:1159.
16. Cobbold, S. P., A. Jayasuriya, A. Nash, T. D. Prospero, and H. Waldmann 1984. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature 312:548.
17. Gegin, C., and F. Lehmann-Grube. 1992. Control of acute infection with lymphocytic choriomeningitis virus in mice that cannot present an immunodominant viral cytotoxic T lymphocyte epitope. J. Immunol. 149:3331
18. 51Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology 14:181.
19. Miltenyi, S., W. Müller, W Weichel, and A. Radbruch. 1990. High gradient magnetic cell separation with MACS. Cytometry 11:231.
20. b-restricted determinant in simian virus 40 tumor antigen. Virology 208:159.
21. Pfizenmaier, K., G. Trinchieri, D. Solter, and B. B. Knowles. 1978 Mapping of H-2 genes associated with T cell-mediated cytotoxic responses to SV40-tumour-associated specific antigens. Nature 274:691.
22. Knowles, B. B., M. Koncar, K. Pfizenmaier, D. Solter, D. P. Aden, and G. Trinchieri. 1979. Genetic control of the cytotoxic T cell response to SV40 tumor-associated specific antigen. J. Immunol. 122:1798
23. Pfizenmaier, K , S.-H. Pan, and B. B. Knowles. 1980. Preferential H-2 association in cytotoxic T cell responses to SV40 tumor-associated specific antigens. J. Immunol. 124:1888.
24. Pan, S., J. Abramczuk, and B. B Knowles. 1987 Immune control of SV40-induced tumors in mice. Int. J Cancer 39:722.
25. Bright, R K., M. H Shearer, and R. C Kennedy. 1994. Immunization of BALB/c mice with recombinant simian 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells: an antibody-based mechanism for tumor immunity. J. Immunol. 153:2064
26. Bright, R. K., M. H. Shearer, and R. C. Kennedy 1995. Nucleic acid vaccination against virally induced tumors. Ann. N Y. Acad. Sci. 772:241.
27. Fanning, E., and R. Knippers 1992. Structure and function of simian virus 40 large tumor antigen Annu. Rev. Biochem 61:55.
28. 40-tumorigenesis in mouse. Acta Pathol. Microbiol. Scand. Sect. B 78:479.
29. Wright, P. W., H. S. Smith, and J. McCoy 1973. Tumorigenicity and antigenicity of mouse cells infected with simian virus 40. I. Relationship of growth in vitro and in vivo in immunosuppressed and immunocompetent recipients. J Natl. Cancer Inst 51:951.
30. Shearer, M. H , R K. Bright, R. E. Lanford, and R. C. Kennedy. 1993. Immunization of mice with baculovirus-derived recombinant SV40 large tumour antigen induces protective tumour immunity to a lethal challenge with SV40-transformed cells Clin Exp. Immunol. 91:266
31. Hanagarth, H.-G., M Obert, R. Hess, C. Haessler, D. G. Braun, and G. Brandner. 1994. The cell-binding carboxyterminal undecapeptide of SV40 tumour antigen provides protective cell-dependent immunity. Vaccine 12:1197.
32. Bright, R. K., M H. Shearer, and R. C Kennedy. 1995. Examination of lymphokines induced in mice following immunization with recombinant simian virus 40 large tumor antigen Cancer Immunol. Immunother 40:206
33. Zarling, J M., and S. S. Tevethia. 1973 Transplantation immunity to simian virus 40-transformed cells in tumor-bearing mice. I. Development of cellular immunity to simian virus 40 tumor-specific transplantation antigens during tumorigenesis by transplanted cells. J. Natl. Cancer Inst 50:137.
34. Tevethia, S. S , J. W. Blasecki, G. Waneck, and A L. Goldstein. 1974 Requirement of thymus-derived Θ-positive lymphocytes for rejection of DNA virus (SV40) tumors in mice. J. Immunol. 113:1417.
35. Gooding, L. R. 1979. Specificities of killing by T lymphocytes generated against syngeneic SV40 transformants: studies employing recombinants within the H-2 complex J. Immunol. 122:1002.
36. Tevethia, S. S., D. C. Flyer, and R. Tjian. 1980. Biology of simian virus 40 (SV40) transplantation antigen (TrAg). VI. Mechanism of induction of SV40 transplantation immunity in mice by purified SV40 T antigen (D2 protein). Virology 107:13.
37. Berke, G , and B. Schick. 1980 Tumor immunity in the peritoneal cavity. Contemp Top. Immunobiol. 10:297.
38. Ljunggren, G , H.-G. Ljunggren, and T. Dalianis. 1994. T cell subsets involved in immunity against polyoma virus-induced rumors. Virology 198:714.
39. Zarling, J. M , and S. S. Tevethia. 1973 Transplantation immunity to simian virus 40-transformed cells in tumor-bearing mice. II. Evidence for macrophage participation at the effector level of tumor cell rejection J. Natl. Cancer Inst. 50 149.
40. Chapes, S. K , and L R. Gooding 1985. Evidence for the involvement of cytolytic macrophages in rejection of SV40-induced tumors. J. Immunol. 135:2192.
41. 1 hybrid virus to identify the protein responsible for simian virus 40 tumor rejection and its genetic origin. Proc. Natl Acad. Sci. USA 75:3055
42. Bright, R. K , M H. Shearer, and R. C. Kennedy. 1994. SV40 late tumor antigen associated synthetic peptides define native antigenic determinants and induce protective tumor immunity m mice. Mol Immunol. 31:1077.
43. + T lymphocyte-mediated antiviral immunity in mice as a result of injection of recombinant viral proteins. J. Immunol 153:2554.
44. Schirmbeck, R , K Melber, T. Mertens, and J. Reimann. 1994. Selective stimulation of murine cytotoxic T cell and antibody responses by particulate or monomeric hepatitis B virus surface (S) antigen. Eur. J Immunol. 24:1088.
45. Flyer, D C , and S. S Tevethia 1982. Biology of simian virus 40 (SV40) transplantation antigen (TrAg) VIII. Retention of SV40 TrAg sites on purified SV40 large T antigen following denaturation with sodium dodecyl sulfate. Virology 117:267.